CurrentEndo
Get Weekly

Topic · page 10 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 361–400 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Obes Metab

    Pharmacokinetics and Food Effect of HDM1002 , a Novel Oral Small‐Molecule GLP ‐1 Receptor Agonist, in Healthy Chinese Volunteers: A Bioequivalence Study

    Randomized controlled trial

  2. Diabetes Obes Metab

    Prescribing Trajectories in Type 2 Diabetes in the United States, 2019–2024

    Cohort study

  3. Diabetes Care

    National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs Among U.S. Adults With Diabetes, 2000–2022

    Cross-sectional study

  4. Diabetes Obes Metab

    Combining Sodium–Glucose Co‐Transporter‐2 Inhibitor Plus Glucagon‐Like Peptide‐1 Receptor Agonist for Glucose‐Lowering in Type 2 Diabetes: Effects of Drug Initiation Sequence on Kidney Function in Real‐World Clinical Practice ( CombiKid Study)

    Cohort study

  5. Cardiovasc Diabetol

    Cardioprotective glucose-lowering drugs, statins, and secondary major adverse cardiovascular events: a nationwide cohort study of individuals with type 2 diabetes and cardiovascular disease

    Cohort study

  6. Diabetes Obes Metab

    Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta‐Analysis

    Meta-analysis

  7. Diabetes Obes Metab

    Dose–Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case–Control Study

    Cohort study

  8. Diabetes Obes Metab

    Endothelial Function Is Associated With Incident Diabetes Mellitus: The ELSA ‐Brasil Cohort Study

    Cohort study

  9. Diabet Med

    Glycaemic penalty index as an independent predictor of healthcare‐associated infection in surgical inpatients: A nested cohort study from the STOIC ‐D surgery trial

    Randomized controlled trial

  10. Diabetes Obes Metab

    Type 2 Diabetes Is Associated With Increased Complications and Mortality After Hip Fracture in Older Adults Aged 60 Years or Older

    Cohort study

  11. Diabetes Res Clin Pract

    Analysis of plasma extracellular vesicles in normal-weight and overweight type 2 diabetes mellitus using multimodal SERS and RNA-Seq

    Cross-sectional study

  12. Cardiovasc Diabetol

    Head-to-head comparison of fasting-insulin-based versus non-insulin-based insulin resistance surrogates for predicting all-cause and cardiovascular mortality in hypertensive adults across the glycemic continuum: a prospective cohort study

    Cohort study

  13. Cardiovasc Diabetol

    Prognostic Value of Coronary CT Angiography Among Patients With and Without Diabetes: The Mass General Brigham CCTA registry

    Cohort study

  14. Diabetes Obes Metab

    Association of Reduction in Continuity of Care During COVID ‐19 Pandemic With Cardiovascular Diseases, Kidney Failure and All‐Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong

    Cohort study

  15. Diabetes Obes Metab

    Elevated Cardiovascular Risk and Mortality in Type 2 Diabetes Mellitus Patients With Cannabis, Opioid, and Cocaine Use Disorders

    Cohort study

  16. Diabetes Obes Metab

    Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant‐Level Exploratory Analysis of the Randomised CONFIDENCE Trial

    Secondary analysis

  17. Diabetes Obes Metab

    Smartphone‐Based Automated Basal Insulin Titration During Ramadan Fasting: Data From Adults With Type 2 Diabetes in Saudi Arabia

    Cohort study

  18. Diabetes Obes Metab

    Subgroups of Adult‐Onset Diabetes: A Prospective Follow‐Up Study of Progression of Insulin Resistance and Deficiency and Association With Liver Steatosis and Fibrosis

    Cohort study

  19. Diabetes Obes Metab

    T2D Management Among a Community Clinic Patient Sample After California's May 2022 Medicaid Expansion

    Cohort study

  20. Diabetes Res Clin Pract

    Exercise snacks to combat hyperglycaemia in patients with abnormal glycaemic control: Use of a novel strategy based on individual continuous glucose data in a real-world setting

    Randomized controlled trial

  21. Diabetes Res Clin Pract

    Glycemic trajectory after face-to-face diabetes self-management education: a dose–response meta-analysis

    Meta-analysis

  22. Diabetes Res Clin Pract

    Complementary value of glycated albumin and continuous glucose monitoring for assessing microvascular complications in type 2 diabetes

    Cross-sectional study

  23. Diabetes Res Clin Pract

    Health behavior changes after type 2 diabetes diagnosis: a 16-year longitudinal cohort study

    Cohort study

  24. Cardiovasc Diabetol

    Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a prospective cohort study

    Cohort study

  25. J Diabetes Sci Technol

    Changes in HbA1c With Glucagon-Like Peptide-1 Receptor Agonist Therapy Alone and Followed by Initiation of Continuous Glucose Monitoring: A Retrospective Analysis of U.S. Medical Claims Data

    Cohort study

  26. Diabetes Obes Metab

    Healthcare Cost Trends in New Users of SGLT ‐2i, DPP ‐4i and GLP ‐1 RA for Type 2 Diabetes: An Observational Longitudinal Study

    Cohort study

  27. Diabetes Res Clin Pract

    Kidney measures and cerebral white matter hyperintensity severity in chronic kidney disease stratified by type 2 diabetes mellitus status

    Cross-sectional study

  28. Cardiovasc Diabetol

    Apolipoprotein B100 predicts cardiovascular and limb events in type 2 diabetes patients with chronic limb-threatening ischemia

    Cohort study

  29. Cardiovasc Diabetol

    Integrating inflammation, insulin resistance, and visceral adiposity: the C-reactive protein–triglyceride–glucose-Chinese visceral adiposity (CTI–CVAI) index is associated with cardiovascular disease risk across CKM stages 0–3 in a nationwide prospective cohort

    Cohort study

  30. BMJ Open Diabetes Res Care

    Factors associated with hypoglycemic or hyperglycemic events during Ramadan among persons with diabetes in Qatar

    Cohort study

  31. Cardiovasc Diabetol

    Estimated glucose disposal rate outperforms inflammation surrogate markers in predicting cardiometabolic multimorbidity among middle-aged and older adults

    Cohort study

  32. Pediatr Diabetes

    Diverging regional inequalities in childhood diabetes, 1990–2023: a GBD 2023-based analysis

    Cross-sectional study

  33. Diabetes Res Clin Pract

    GLP-1 receptor agonist adjunct therapy stabilises Ramadan dysglycaemia in insulin-treated diabetes: a CGM-based study

    Cohort study

  34. Diabetes Obes Metab

    Nationwide Real‐World Retrospective Study of Oral Semaglutide Use in Adults Living With Type 2 Diabetes in F inland

    Cohort study

  35. Diabetes Res Clin Pract

    Association of glycemic control with arterial stiffness and hemodynamic function in type 2 diabetes mellitus

    Cross-sectional study

  36. Lancet

    Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial

    Randomized controlled trial

  37. Lancet

    Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial

    Randomized controlled trial

  38. Diabetes Care

    Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study

    Cohort study

  39. Diabetes Care

    Enzymatic 2-Hydroxybutyrate Measurement for Dysglycemia Screening Beyond Conventional Fasting Measures

    Diagnostic or prognostic study

  40. Nat Med

    Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants

    Secondary analysis

All 4,758 Briefs in ExploreShowing Briefs 361–400 of 4,758, newest first